drugset / Trial / NCT00837863
Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the safety and effectiveness of ALTU-238 in the treatment of children with growth hormone deficiency who have not yet reached puberty who lack the normal ability to make growth hormone themselves. This study will also test if ALTU-238 works as a weekly treatment.
Timeline
- Start
- 2009-03
- Primary completion
- 2010-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Somatropin | Protein / enzyme biologic | 0.043 mg/kg | — |
| Comparator | Somatropin | Protein / enzyme biologic | 0.3 mg/kg | — |
| Comparator | Somatropin | Protein / enzyme biologic | 0.6 mg/kg | — |
| Comparator | Somatropin | Protein / enzyme biologic | 0.9 mg/kg | — |